EMA: Chmp Considered That Data From Ongoing EMA Review Raise Serious Concerns About Safety of Oxbryta Due to Increased Uncertainties
EMA:歐盟藥品評估委員會(CHMP)認爲,來自正在進行的EMA審查的數據引發了對Oxbryta安全性的嚴重關注,因爲存在更多不確定性。
EMA: Chmp Considered That Data From Ongoing EMA Review Raise Serious Concerns About Safety of Oxbryta Due to Increased Uncertainties
EMA:歐盟藥品評估委員會(CHMP)認爲,來自正在進行的EMA審查的數據引發了對Oxbryta安全性的嚴重關注,因爲存在更多不確定性。
譯文內容由第三人軟體翻譯。